Skip to contentM
Moleculin Biotech, Inc.
M
MBRXMoleculin Biotech, Inc. Q1 2021 · 10-Q
Revenue$0.00$0.00— vs Q1 2020 Net Income-$4.45M-$4.45MN/M vs Q1 2020 EPS Diluted-$0.20-$0.20N/M vs Q1 2020 Operating Income-$6,088,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Moleculin Biotech, Inc. · CIK 1659617 · Engraved from SEC EDGAR
Free Cash Flowderived-$3,624,000N/M ended Mar 31, 2021 · filed May 12, 2021 · 42 d after period end